JG
FULC icon

Jain Global’s Fulcrum Therapeutics FULC Stock Holding History

Jain Global’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9K Buy
+15,260
New +$92.8K ﹤0.01% 1667
2026
Q1 		– Sell
-41,260
Closed -$467K – 1365
2025
Q4 		$467K Buy
+41,260
New +$420K ﹤0.01% 850
2025
Q2 		– Sell
-13,051
Closed -$37.6K – 1339
2025
Q1 		$37.6K Sell
13,051
-2,358
-15% -$8.66K ﹤0.01% 1023
2024
Q4 		$72.4K Buy
+15,409
New +$56.8K ﹤0.01% 704

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jain Global's FULC Position: Q2 2026 in Review

Jain Global opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 15,260 shares worth $55.9K. The stake represents ﹤0.01% of the portfolio and ranks #1667 among its holdings. This is a return to the name: Jain Global previously reported a position in FULC as recently as Q4 2025.

Jain Global first reported a position in FULC in Q4 2024 and has held it in 4 quarters since. The position peaked at $467K in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Jain Global held 15,260 shares of Fulcrum Therapeutics worth $55.9K as of Q2 2026.
  • Fulcrum Therapeutics was a new Jain Global position in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1667 holding.
  • Jain Global first reported a position in Fulcrum Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's Fulcrum Therapeutics position peaked at $467K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.